Clinical trial
Preventive Therapy for Tuberculosis in HIV Infected Persons
NCT00351702 · Tuberculosis Research Centre, India, Other · Completed
Key facts
| NCT number | NCT00351702 |
|---|---|
| Title | Preventive Therapy for Tuberculosis in HIV Infected Persons |
| Official title | Evaluation of Two Different Preventive Therapy Regimens for Tuberculosis in HIV Infected Persons |
| Lead sponsor | Tuberculosis Research Centre, India, Other |
| Collaborators | United States Agency for International Development (USAID) U.S. Fed |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Human Immunodeficiency Virus, Tuberculosis |
| Intervention type | Drug |
| Interventions | Isoniazid with Ethambutol |
| Enrollment | 683 |
| Start date | Feb 1, 2001 |
| Primary completion | Sep 1, 2008 |
| Completion | Jun 1, 2011 |
| First posted | Jul 13, 2006 |
| Last update posted | May 22, 2024 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: